Metsera
Latest round
- Series B
Last raised
- Nov 2024
Total raised
- $271M
Investors
- 17
About Metsera
Based in New York, US, and founded in 2022, Metsera, Inc. is a biopharmaceutical company that develops new treatment strategies for weight loss, weight maintenance, and disease prevention. In September 2025, Pfizer Inc. agreed to fully acquire Metsera, Inc.60 per share, or USD 7 billion in cash. As part of the transaction, Pfizer, Inc.65 per share in potential additional payments subject to Metsera achieving certain milestones.
Who invested in Metsera
17 investors across 2 rounds
See all investors in Metsera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Metsera
Who invested in Metsera?
Metsera has 17 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metsera raised?
Metsera has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Metsera last raise money?
Metsera's most recent round on record is a Series B, in Nov 2024.
What does Metsera do?
Based in New York, US, and founded in 2022, Metsera, Inc.
Where is Metsera headquartered?
Metsera is headquartered in New York, US.
Which VCs invest in companies like Metsera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Metsera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Metsera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.